News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,306 Results
Type
Article (43589)
Company Profile (315)
Press Release (675402)
Section
Business (211673)
Career Advice (2091)
Deals (36373)
Drug Delivery (94)
Drug Development (82159)
Employer Resources (173)
FDA (16674)
Job Trends (15284)
News (355747)
Policy (33341)
Tag
Academia (2683)
Alliances (52311)
Alzheimer's disease (1321)
Approvals (16640)
Artificial intelligence (202)
Bankruptcy (359)
Best Places to Work (11914)
Biotechnology (222)
Breast cancer (218)
Cancer (1614)
Cardiovascular disease (123)
Career advice (1747)
CAR-T (119)
Cell therapy (338)
Clinical research (65832)
Collaboration (634)
Compensation (317)
COVID-19 (2641)
C-suite (147)
Data (1533)
Diabetes (196)
Diagnostics (6500)
Earnings (86738)
Employer resources (151)
Events (115202)
Executive appointments (536)
FDA (17508)
Funding (569)
Gene therapy (237)
GLP-1 (653)
Government (4450)
Healthcare (19460)
Infectious disease (2741)
Inflammatory bowel disease (117)
Interviews (320)
IPO (16763)
Job creations (3815)
Job search strategy (1490)
Layoffs (443)
Legal (8096)
Lung cancer (237)
Manufacturing (227)
Medical device (13975)
Medtech (13980)
Mergers & acquisitions (19926)
Metabolic disorders (523)
Neuroscience (1704)
NextGen: Class of 2025 (6839)
Non-profit (4611)
Northern California (1947)
Obesity (296)
Opinion (200)
Patents (144)
People (58929)
Phase I (20649)
Phase II (28970)
Phase III (21498)
Pipeline (642)
Postmarket research (2581)
Preclinical (8814)
Radiopharmaceuticals (258)
Rare diseases (305)
Real estate (6222)
Regulatory (22407)
Research institute (2450)
Resumes & cover letters (361)
Southern California (1694)
Startups (3832)
United States (17669)
Vaccines (619)
Weight loss (206)
Date
Today (56)
Last 7 days (635)
Last 30 days (2717)
Last 365 days (35662)
2025 (2727)
2024 (36221)
2023 (41136)
2022 (52397)
2021 (56994)
2020 (55615)
2019 (48410)
2018 (36442)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (754)
Arizona (215)
Asia (40094)
Australia (6669)
California (4490)
Canada (1614)
China (378)
Colorado (204)
Connecticut (218)
Europe (87570)
Florida (639)
Georgia (163)
Illinois (454)
Indiana (255)
Maryland (709)
Massachusetts (3497)
Michigan (206)
Minnesota (330)
New Jersey (1266)
New York (1284)
North Carolina (842)
Northern California (1947)
Ohio (164)
Pennsylvania (1040)
South America (1151)
Southern California (1694)
Texas (656)
Utah (133)
Washington State (448)
719,306 Results for "neonc technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
NeOnc Technologies Receives FDA Approval to Expand NEO100-01™ Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation
July 16, 2024
·
7 min read
Press Releases
NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate
August 5, 2024
·
6 min read
Biotech Beach
NeOnc Technologies Completes $10.0 Million Equity Funding Round
NeOnc Technologies Holdings, Inc., a clinical stage medical biotechnology company, has completed a $10.0 million equity funding round at a post-money valuation of $70 million.
February 8, 2023
·
4 min read
Press Releases
NeOnc Initiates Cohort 3 in Phase 1 Clinical Trial of NEO212™, a Patented Novel Hybrid Drug Designed to Deliver ‘Double Punch’ Against Malignant Brain Tumors
July 25, 2024
·
6 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Press Releases
Improzo Inc. Revolutionizes Healthcare Consulting With Advanced Technology and Expert Leadership
January 27, 2025
·
5 min read
Press Releases
Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer
January 27, 2025
·
2 min read
Press Releases
Healthcare Integrated Technologies, Inc. Promotes Dustin Hillis to President
December 30, 2024
·
2 min read
Press Releases
Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering
January 28, 2025
·
6 min read
Press Releases
FOXO TECHNOLOGIES INC., CONFIRMS DETAILS OF SPECIAL MEETING OF SHAREHOLDERS ON JANUARY 17, 2025.
January 16, 2025
·
4 min read
1 of 71,931
Next
